May 04, 2026
While investors have been trying hard to look past the situation in the Middle East, it may get more difficult (and dangerous) to do so … as the U.S. claims it will “guide” ships through the Strait of Hormuz while there are unconfirmed Iranian reports that a U.S. warship was targeted and hit.
More
May 01, 2026
Two of the three major U.S. indexes (the S&P and Nasdaq) hit new intraday highs this morning as investors seem to be looking beyond the situation overseas, even amid the continuing uncertainty.
More
Apr 30, 2026
The game of chicken continues in Iran with competing claims heightening the drama.
More
Apr 29, 2026
Stocks are in slight negative territory this morning as it appears the conflict with Iran … initially targeted to last “four to six weeks” is about to enter its third month.
More
Apr 28, 2026
Oil well that ends well. Okay, I didn’t have a better pun about this but just want to point out the very interesting development about OPEC.
More
Apr 27, 2026
Futures point to a timid opening this morning as the war/skirmish/conflict (pick one) with Iran is about to close out its second month, quite a bit longer than original projections.
More
Apr 24, 2026
Stocks are up this morning following the announcement of an extension of the ceasefire with Iran, but this time there is no specific deadline other than the end date being when we see the “discussion concluded” …
More
Apr 22, 2026
Stocks are up this morning following the announcement of an extension of the ceasefire with Iran, but this time there is no specific deadline other than the end date being when we see the “discussion concluded” … leaving much to the imagination.
More
Apr 20, 2026
There is a lot of confusion going on right now as an announcement was made last week by the administration that the Strait of Hormuz was “permanently open” …
More

You are now leaving www.teamemerald.com. Follow the link to learn more about the F/m Emerald Life Sciences Innovation ETF
https://www.emeraldetfs.com/33rd-annual-groundhog-day-exploring-life-sciences-2/ ➜